 | • レポートコード：GIR201114831 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：機械・機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ファーマコゲノミクス（PGx）の世界市場を調査対象にし、ファーマコゲノミクス（PGx）の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ポリメラーゼ連鎖反応（PCR）、マイクロアレイ、シーケンシング、その他）、用途別分析（心血管疾患（CVD）、中枢神経系（CNS）、癌/腫瘍学、感染症、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Abbott Laboratories、Myriad Genetics, Inc.、Astrazeneca、Affymetrix, Inc.、Laboratory Corporation of America Holdings、Assurex Health, Inc、Pfizer, Inc、Illumina, Inc.、GeneDX、Pathway Genomics、Transgenomic, Inc.、Qiagen, Inc.、Thermo Fisher Scientific、Rocheg、Teva Pharmaceutical Industries Ltd. ・企業別売上、市場シェア ・ファーマコゲノミクス（PGx）の地域別市場分析 ・ファーマコゲノミクス（PGx）の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ファーマコゲノミクス（PGx）のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ファーマコゲノミクス（PGx）のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ファーマコゲノミクス（PGx）の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ファーマコゲノミクス（PGx）の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ファーマコゲノミクス（PGx）の種類別市場規模2015-2020：ポリメラーゼ連鎖反応（PCR）、マイクロアレイ、シーケンシング、その他 ・ファーマコゲノミクス（PGx）の用途別市場規模2015-2020：心血管疾患（CVD）、中枢神経系（CNS）、癌/腫瘍学、感染症、その他 ・ファーマコゲノミクス（PGx）の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Pharmacogenomics (PGx) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pharmacogenomics (PGx) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pharmacogenomics (PGx) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pharmacogenomics (PGx) market has been segmented into:
Polymerase Chain Reaction (PCR)
Microarray
Sequencing
Other
By Application, Pharmacogenomics (PGx) has been segmented into:
Cardiovascular Diseases (CVD)
Central Nervous System (CNS)
Cancer/Oncology
Infectious Diseases
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pharmacogenomics (PGx) market presented in the report. This section sheds light on the sales growth of different regional and country-level Pharmacogenomics (PGx) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pharmacogenomics (PGx) market.
The report offers in-depth assessment of the growth and other aspects of the Pharmacogenomics (PGx) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Pharmacogenomics (PGx) Market Share Analysis
Pharmacogenomics (PGx) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pharmacogenomics (PGx) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pharmacogenomics (PGx) sales, revenue and market share for each player covered in this report.
The major players covered in Pharmacogenomics (PGx) are:
Abbott Laboratories
Myriad Genetics, Inc.
Astrazeneca
Affymetrix, Inc.
Laboratory Corporation of America Holdings
Assurex Health, Inc
Pfizer, Inc
Illumina, Inc.
GeneDX
Pathway Genomics
Transgenomic, Inc.
Qiagen, Inc.
Thermo Fisher Scientific
Rocheg
Teva Pharmaceutical Industries Ltd.
1 Pharmacogenomics (PGx) Market Overview
1.1 Product Overview and Scope of Pharmacogenomics (PGx)
1.2 Classification of Pharmacogenomics (PGx) by Type
1.2.1 Global Pharmacogenomics (PGx) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pharmacogenomics (PGx) Revenue Market Share by Type in 2019
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Microarray
1.2.5 Sequencing
1.2.6 Other
1.3 Global Pharmacogenomics (PGx) Market by Application
1.3.1 Overview: Global Pharmacogenomics (PGx) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cardiovascular Diseases (CVD)
1.3.3 Central Nervous System (CNS)
1.3.4 Cancer/Oncology
1.3.5 Infectious Diseases
1.3.6 Other
1.4 Global Pharmacogenomics (PGx) Market by Regions
1.4.1 Global Pharmacogenomics (PGx) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pharmacogenomics (PGx) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Myriad Genetics, Inc.
2.2.1 Myriad Genetics, Inc. Details
2.2.2 Myriad Genetics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Myriad Genetics, Inc. SWOT Analysis
2.2.4 Myriad Genetics, Inc. Product and Services
2.2.5 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astrazeneca
2.3.1 Astrazeneca Details
2.3.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astrazeneca SWOT Analysis
2.3.4 Astrazeneca Product and Services
2.3.5 Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Affymetrix, Inc.
2.4.1 Affymetrix, Inc. Details
2.4.2 Affymetrix, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Affymetrix, Inc. SWOT Analysis
2.4.4 Affymetrix, Inc. Product and Services
2.4.5 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Laboratory Corporation of America Holdings
2.5.1 Laboratory Corporation of America Holdings Details
2.5.2 Laboratory Corporation of America Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Laboratory Corporation of America Holdings SWOT Analysis
2.5.4 Laboratory Corporation of America Holdings Product and Services
2.5.5 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Assurex Health, Inc
2.6.1 Assurex Health, Inc Details
2.6.2 Assurex Health, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Assurex Health, Inc SWOT Analysis
2.6.4 Assurex Health, Inc Product and Services
2.6.5 Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer, Inc
2.7.1 Pfizer, Inc Details
2.7.2 Pfizer, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer, Inc SWOT Analysis
2.7.4 Pfizer, Inc Product and Services
2.7.5 Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Illumina, Inc.
2.8.1 Illumina, Inc. Details
2.8.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Illumina, Inc. SWOT Analysis
2.8.4 Illumina, Inc. Product and Services
2.8.5 Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.9 GeneDX
2.9.1 GeneDX Details
2.9.2 GeneDX Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GeneDX SWOT Analysis
2.9.4 GeneDX Product and Services
2.9.5 GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pathway Genomics
2.10.1 Pathway Genomics Details
2.10.2 Pathway Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pathway Genomics SWOT Analysis
2.10.4 Pathway Genomics Product and Services
2.10.5 Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Transgenomic, Inc.
2.11.1 Transgenomic, Inc. Details
2.11.2 Transgenomic, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Transgenomic, Inc. SWOT Analysis
2.11.4 Transgenomic, Inc. Product and Services
2.11.5 Transgenomic, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Qiagen, Inc.
2.12.1 Qiagen, Inc. Details
2.12.2 Qiagen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Qiagen, Inc. SWOT Analysis
2.12.4 Qiagen, Inc. Product and Services
2.12.5 Qiagen, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.13 Thermo Fisher Scientific
2.13.1 Thermo Fisher Scientific Details
2.13.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Thermo Fisher Scientific SWOT Analysis
2.13.4 Thermo Fisher Scientific Product and Services
2.13.5 Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.14 Rocheg
2.14.1 Rocheg Details
2.14.2 Rocheg Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Rocheg SWOT Analysis
2.14.4 Rocheg Product and Services
2.14.5 Rocheg Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.15 Teva Pharmaceutical Industries Ltd.
2.15.1 Teva Pharmaceutical Industries Ltd. Details
2.15.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis
2.15.4 Teva Pharmaceutical Industries Ltd. Product and Services
2.15.5 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pharmacogenomics (PGx) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pharmacogenomics (PGx) Players Market Share
3.2.2 Top 10 Pharmacogenomics (PGx) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pharmacogenomics (PGx) Revenue and Market Share by Regions
4.2 North America Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.3 Europe Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.5 South America Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
5 North America Pharmacogenomics (PGx) Revenue by Countries
5.1 North America Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
5.2 USA Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
5.3 Canada Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
5.4 Mexico Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6 Europe Pharmacogenomics (PGx) Revenue by Countries
6.1 Europe Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
6.2 Germany Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.3 UK Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.4 France Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.5 Russia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.6 Italy Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pharmacogenomics (PGx) Revenue by Countries
7.1 Asia-Pacific Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
7.2 China Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.3 Japan Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.4 Korea Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.5 India Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
8 South America Pharmacogenomics (PGx) Revenue by Countries
8.1 South America Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
8.2 Brazil Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
8.3 Argentina Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pharmacogenomics (PGx) by Countries
9.1 Middle East & Africa Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9.3 UAE Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9.4 Egypt Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9.5 South Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pharmacogenomics (PGx) Revenue and Market Share by Type (2015-2020)
10.2 Global Pharmacogenomics (PGx) Market Forecast by Type (2019-2024)
10.3 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2025)
10.4 Microarray Revenue Growth Rate (2015-2025)
10.5 Sequencing Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Pharmacogenomics (PGx) Market Segment by Application
11.1 Global Pharmacogenomics (PGx) Revenue Market Share by Application (2015-2020)
11.2 Pharmacogenomics (PGx) Market Forecast by Application (2019-2024)
11.3 Cardiovascular Diseases (CVD) Revenue Growth (2015-2020)
11.4 Central Nervous System (CNS) Revenue Growth (2015-2020)
11.5 Cancer/Oncology Revenue Growth (2015-2020)
11.6 Infectious Diseases Revenue Growth (2015-2020)
11.7 Other Revenue Growth (2015-2020)
12 Global Pharmacogenomics (PGx) Market Size Forecast (2021-2025)
12.1 Global Pharmacogenomics (PGx) Market Size Forecast (2021-2025)
12.2 Global Pharmacogenomics (PGx) Market Forecast by Regions (2021-2025)
12.3 North America Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.4 Europe Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.6 South America Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Pharmacogenomics (PGx) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pharmacogenomics (PGx) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pharmacogenomics (PGx) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pharmacogenomics (PGx) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Pharmacogenomics (PGx) Major Business
Table 7. Abbott Laboratories Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Pharmacogenomics (PGx) Product and Solutions
Table 10. Abbott Laboratories Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Myriad Genetics, Inc. Corporate Information, Location and Competitors
Table 12. Myriad Genetics, Inc. Pharmacogenomics (PGx) Major Business
Table 13. Myriad Genetics, Inc. Pharmacogenomics (PGx) Total Revenue (USD Million) (2018-2019)
Table 14. Myriad Genetics, Inc. SWOT Analysis
Table 15. Myriad Genetics, Inc. Pharmacogenomics (PGx) Product and Solutions
Table 16. Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Astrazeneca Corporate Information, Location and Competitors
Table 18. Astrazeneca Pharmacogenomics (PGx) Major Business
Table 19. Astrazeneca Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 20. Astrazeneca SWOT Analysis
Table 21. Astrazeneca Pharmacogenomics (PGx) Product and Solutions
Table 22. Astrazeneca Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Affymetrix, Inc. Corporate Information, Location and Competitors
Table 24. Affymetrix, Inc. Pharmacogenomics (PGx) Major Business
Table 25. Affymetrix, Inc. Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 26. Affymetrix, Inc. SWOT Analysis
Table 27. Affymetrix, Inc. Pharmacogenomics (PGx) Product and Solutions
Table 28. Affymetrix, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Laboratory Corporation of America Holdings Corporate Information, Location and Competitors
Table 30. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Major Business
Table 31. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 32. Laboratory Corporation of America Holdings SWOT Analysis
Table 33. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product and Solutions
Table 34. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Assurex Health, Inc Corporate Information, Location and Competitors
Table 36. Assurex Health, Inc Pharmacogenomics (PGx) Major Business
Table 37. Assurex Health, Inc Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 38. Assurex Health, Inc SWOT Analysis
Table 39. Assurex Health, Inc Pharmacogenomics (PGx) Product and Solutions
Table 40. Assurex Health, Inc Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Pfizer, Inc Corporate Information, Location and Competitors
Table 42. Pfizer, Inc Pharmacogenomics (PGx) Major Business
Table 43. Pfizer, Inc Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 44. Pfizer, Inc SWOT Analysis
Table 45. Pfizer, Inc Pharmacogenomics (PGx) Product and Solutions
Table 46. Pfizer, Inc Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Illumina, Inc. Corporate Information, Location and Competitors
Table 48. Illumina, Inc. Pharmacogenomics (PGx) Major Business
Table 49. Illumina, Inc. Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 50. Illumina, Inc. SWOT Analysis
Table 51. Illumina, Inc. Pharmacogenomics (PGx) Product and Solutions
Table 52. Illumina, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GeneDX Corporate Information, Location and Competitors
Table 54. GeneDX Pharmacogenomics (PGx) Major Business
Table 55. GeneDX Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 56. GeneDX SWOT Analysis
Table 57. GeneDX Pharmacogenomics (PGx) Product and Solutions
Table 58. GeneDX Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pathway Genomics Corporate Information, Location and Competitors
Table 60. Pathway Genomics Pharmacogenomics (PGx) Major Business
Table 61. Pathway Genomics Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 62. Pathway Genomics SWOT Analysis
Table 63. Pathway Genomics Pharmacogenomics (PGx) Product and Solutions
Table 64. Pathway Genomics Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Transgenomic, Inc. Corporate Information, Location and Competitors
Table 66. Transgenomic, Inc. Pharmacogenomics (PGx) Major Business
Table 67. Transgenomic, Inc. Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 68. Transgenomic, Inc. SWOT Analysis
Table 69. Transgenomic, Inc. Pharmacogenomics (PGx) Product and Solutions
Table 70. Transgenomic, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Qiagen, Inc. Corporate Information, Location and Competitors
Table 72. Qiagen, Inc. Pharmacogenomics (PGx) Major Business
Table 73. Qiagen, Inc. Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 74. Qiagen, Inc. SWOT Analysis
Table 75. Qiagen, Inc. Pharmacogenomics (PGx) Product and Solutions
Table 76. Qiagen, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 78. Thermo Fisher Scientific Pharmacogenomics (PGx) Major Business
Table 79. Thermo Fisher Scientific Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 80. Thermo Fisher Scientific SWOT Analysis
Table 81. Thermo Fisher Scientific Pharmacogenomics (PGx) Product and Solutions
Table 82. Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Rocheg Corporate Information, Location and Competitors
Table 84. Rocheg Pharmacogenomics (PGx) Major Business
Table 85. Rocheg Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 86. Rocheg SWOT Analysis
Table 87. Rocheg Pharmacogenomics (PGx) Product and Solutions
Table 88. Rocheg Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Teva Pharmaceutical Industries Ltd. Corporate Information, Location and Competitors
Table 90. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Major Business
Table 91. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Total Revenue (USD Million) (2017-2018)
Table 92. Teva Pharmaceutical Industries Ltd. SWOT Analysis
Table 93. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product and Solutions
Table 94. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Pharmacogenomics (PGx) Revenue (Million USD) by Players (2015-2020)
Table 96. Global Pharmacogenomics (PGx) Revenue Share by Players (2015-2020)
Table 97. Global Pharmacogenomics (PGx) Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Pharmacogenomics (PGx) Revenue Market Share by Regions (2015-2020)
Table 99. North America Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
Table 100. North America Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)
Table 101. Europe Pharmacogenomics (PGx) Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Pharmacogenomics (PGx) Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
Table 104. South America Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Pharmacogenomics (PGx) Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)
Table 107. Global Pharmacogenomics (PGx) Revenue (Million USD) by Type (2015-2020)
Table 108. Global Pharmacogenomics (PGx) Revenue Share by Type (2015-2020)
Table 109. Global Pharmacogenomics (PGx) Revenue Forecast by Type (2021-2025)
Table 110. Global Pharmacogenomics (PGx) Revenue by Application (2015-2020)
Table 111. Global Pharmacogenomics (PGx) Revenue Share by Application (2015-2020)
Table 112. Global Pharmacogenomics (PGx) Revenue Forecast by Application (2021-2025)
Table 113. Global Pharmacogenomics (PGx) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pharmacogenomics (PGx) Picture
Figure 2. Global Pharmacogenomics (PGx) Revenue Market Share by Type in 2019
Figure 3. Polymerase Chain Reaction (PCR) Picture
Figure 4. Microarray Picture
Figure 5. Sequencing Picture
Figure 6. Other Picture
Figure 7. Pharmacogenomics (PGx) Revenue Market Share by Application in 2019
Figure 8. Cardiovascular Diseases (CVD) Picture
Figure 9. Central Nervous System (CNS) Picture
Figure 10. Cancer/Oncology Picture
Figure 11. Infectious Diseases Picture
Figure 12. Other Picture
Figure 13. Global Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Pharmacogenomics (PGx) Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Pharmacogenomics (PGx) Revenue Market Share in 2019
Figure 22. Global Top 10 Players Pharmacogenomics (PGx) Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Pharmacogenomics (PGx) Revenue Market Share by Regions (2015-2020)
Figure 26. Global Pharmacogenomics (PGx) Revenue Market Share by Regions in 2018
Figure 27. North America Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 28. Europe Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 30. South America Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 32. North America Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)
Figure 33. North America Pharmacogenomics (PGx) Revenue Market Share by Countries in 2019
Figure 34. USA Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 35. Canada Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 37. Europe Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Pharmacogenomics (PGx) Revenue Market Share by Countries in 2019
Figure 39. Germany Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 40. UK Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 41. France Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 42. Russia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 43. Italy Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Pharmacogenomics (PGx) Revenue Market Share by Countries in 2019
Figure 46. China Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 47. Japan Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 48. Korea Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 49. India Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 51. South America Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)
Figure 52. South America Pharmacogenomics (PGx) Revenue Market Share by Countries in 2019
Figure 53. Brazil Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Pharmacogenomics (PGx) Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Pharmacogenomics (PGx) Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 58. UAE Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
Figure 61. Global Pharmacogenomics (PGx) Revenue Share by Type (2015-2020)
Figure 62. Global Pharmacogenomics (PGx) Revenue Share by Type in 2019
Figure 63. Global Pharmacogenomics (PGx) Market Share Forecast by Type (2021-2025)
Figure 64. Global Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2020)
Figure 65. Global Microarray Revenue Growth Rate (2015-2020)
Figure 66. Global Sequencing Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Pharmacogenomics (PGx) Revenue Share by Application (2015-2020)
Figure 69. Global Pharmacogenomics (PGx) Revenue Share by Application in 2019
Figure 70. Global Pharmacogenomics (PGx) Market Share Forecast by Application (2021-2025)
Figure 71. Global Cardiovascular Diseases (CVD) Revenue Growth Rate (2015-2020)
Figure 72. Global Central Nervous System (CNS) Revenue Growth Rate (2015-2020)
Figure 73. Global Cancer/Oncology Revenue Growth Rate (2015-2020)
Figure 74. Global Infectious Diseases Revenue Growth Rate (2015-2020)
Figure 75. Global Other Revenue Growth Rate (2015-2020)
Figure 76. Global Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Pharmacogenomics (PGx) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Pharmacogenomics (PGx) Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
Figure 80. Europe Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
Figure 82. South America Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
ポリメラーゼ連鎖反応技術の世界市場 2020年 Market Overview The global Polymerase Chain Reaction Technology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Polymera…- 遺伝カウンセリングの世界市場 2020年 Market Overview The Genetic Counseling market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 農業用DNAマイクロアレイの世界市場 2020年 Market Overview The DNA Microarray for Agriculture market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- DNAシーケンス技術の世界市場 2020年 Market Overview The global DNA Sequencing Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The DNA Sequencing Te…
- デジタルフォレンジックテクノロジーの世界市場 2020年 Market Overview The global Digital Forensic Technology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Digital Forensic …